Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,132 Diabetes
clinical trials

Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Brooksville, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Lincoln, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Nampa, ID
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
South Chesterfield, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
Glycogen Storage Disease Type II Pompe Disease Clinical Trial
NeoGAA Extension Study
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
The WISE (Weightloss Intervention Surgical Effects) Brain Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida - College of Public Health and Health Professions
mi
from
Gainesville, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Memorial Hermann South West
mi
from
Houston, TX
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
The Center for Wound Healing Cabell Huntington Hospital
mi
from
Huntington, WV
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
St. Luke's Wound and Hyperbaric Center
mi
from
Meridian, ID
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
The Wound Center of Niagara
mi
from
Niagara Falls, NY
Click here to add this to my saved trials
Neuropathic Diabetic Ulcer - Foot Clinical Trial
A Multi-Center, Prospective, Open Label Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.
Status: Enrolling, Phase II
Updated: 4/5/2016
Amun Research
mi
from
Miami, FL
Click here to add this to my saved trials
Pre-Diabetes Clinical Trial
Improving Beta Cell Function in Mexican American Women With Prediabetes
Status: Enrolling, Phase IV
Updated: 4/3/2018
Denver Harbor Multi-service Center
mi
from
Houston, TX
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Avon, IN
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Call for Information (Investigational Site 0128)
mi
from
La Joya, TX
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Harbor City, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Harleysville, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Hazelwood, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Mandeville, LA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
McMurray, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
San Ramon, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Suwanee, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Clarksburg, WV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Dunwoody, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Franklin, OH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Huntington Park, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Manhattan, KS
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Media, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Saint Cloud, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Wichita, KS
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
TODAY2 Phase 2 Follow-up
Status: Enrolling, Phase
Updated: 2/28/2018
SUNY Upstate New York University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Pompe Disease Clinical Trial
First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Women's and Children's Hospital-Adelaide
mi
from
North Adelaide,
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 4/4/2017
Clinical Research Facility
mi
from
California, CA
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 4/4/2017
Clinical Research Facility
mi
from
New Mexico, NM
Click here to add this to my saved trials
Endocrinology Clinical Trial
The Management of Diabetes in Everyday Life Program
Status: Enrolling
Updated: 11/17/2016
Hawkins Family Medicine
mi
from
Holly Springs, MS
Click here to add this to my saved trials
Endocrinology Clinical Trial
The Management of Diabetes in Everyday Life Program
Status: Enrolling
Updated: 11/17/2016
Christ Community Health Center - Raleigh Health Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Diabetes Clinical Trial
Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients
Status: Enrolling
Updated: 12/31/1969
UAMS Family Medical Center Jonesboro
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Diabetes Clinical Trial
Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients
Status: Enrolling
Updated: 12/31/1969
UAMS Family Medical Center Pine Bluff
mi
from
Pine Bluff, AR
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Endocrine Consultants Research
mi
from
Columbus, GA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Center for Endocrinology & Metabolism
mi
from
Orlando, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Valhalla, NY
Click here to add this to my saved trials
Diabetes Mellitus Clinical Trial
Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk
Status: Enrolling
Updated: 12/31/1969
Sheba Medical Center
mi
from
Ramat Gan,
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus Patients
Status: Enrolling, Phase III
Updated: 1/25/2016
Mylan Investigator Site
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lynn Institute of Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Spectrum Clinical Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
1 … 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 … 41